NASDAQ:CBPO
Delisted

China Biologic Products Stock Forecast

$119.99
+0 (+0%)
At Close: May 27, 2022
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for China Biologic Products Stock and on which exchange is it traded?
The symbol for China Biologic Products is CBPO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell China Biologic Products Stock?
China Biologic Products holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy China Biologic Products Stock?
China Biologic Products Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy China Biologic Products Stock.

What's the current price of China Biologic Products Stock?
As of the end of day on the 2022-05-27, the price of an China Biologic Products (CBPO) share was $119.99.

What is the 52-week high and low for China Biologic Products Stock?
The 52-week high for China Biologic Products Stock is $119.99 and the 52-week low is $119.99.
Click to get the best stock tips daily for free!

About China Biologic Products

China Biologic Products China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People’s Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, ... CBPO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT